Oxycodone and Pregabalin

PreclinicalSmall molecule

Oxycodone and Pregabalin is one of 5 small molecule programs targeting Chronic Post-surgical Pain. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Post-Surgical PainRecruiting

Chronic Post-Surgical PainPreclinical

Recruiting

Competition

Competitive Landscape

4 competitors in Chronic Post-Surgical Pain

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

1 2

Olinvyk

TTrevena Inc.

Approved

1 3

Sufenta

LLeaf Vertical Inc.

Approved

1 4

Morphine Pca

OOndokuz Mayıs University

Preclinical

1 5

Oxycodone and Pregabalin

BBeijing Tiantan Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Chronic Post-surgical Pain1 trial

Effects of Oxycodone Combined With Pregabalin on Chronic Postsurgical Pain in Spinal Surgery

Recruiting·—·N/A·NCT05795478·264 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Oxycodone and Pregabalin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Oxycodone and Pregabalin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Oxycodone and Pregabalin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Beijing Tiantan Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: BBeijing Tiantan Hospital

Oxycodone and Pregabalin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Chronic Post-surgical Pain1 trial

References

Drug Info

Quick Facts

Related News